Keyphrases
Amyloid Pathology
100%
Farnesyltransferase Inhibitor
100%
Axonal Dystrophy
100%
Dystrophic Neurites
75%
5xFAD
62%
Endolysosomal
50%
Farnesyltransferase
50%
Lonafarnib
37%
β-site APP-cleaving Enzyme 1 (BACE1)
25%
Tau Hyperphosphorylation
25%
LAMP1
25%
Axonal Trafficking
25%
Neurodegenerative Diseases
12%
Acute Treatment
12%
Microtubules
12%
Therapeutic Target
12%
Plaque
12%
Plaque Burden
12%
Downstream Signaling
12%
Post-translational Modification
12%
Early Events
12%
Lysosome
12%
Amyloid Deposition
12%
Learning Impairment
12%
Primary Neurons
12%
Biogenesis
12%
Therapeutic Implications
12%
Axonal Degeneration
12%
Autophagic
12%
Memory Deficits
12%
Farnesylation
12%
Microtubule Stability
12%
Amyloid Plaques
12%
Inhibitor Treatment
12%
Mouse Primary Neuron
12%
Retrograde Axonal Transport
12%
Proteinopathy
12%
Plaque Deposition
12%
Amyloid Precursor Protein
12%
AD Pathogenesis
12%
Amyloid Plaque Deposition
12%
Late Endosome
12%
Lysosome Function
12%
Lysotracker Green
12%
Neuroscience
Nerve Fiber Degeneration
100%
Amyloid Protein
100%
Farnesyltransferase Inhibitor
100%
Neurite
75%
Lonafarnib
37%
Microtubules
25%
Lysosomes
25%
Hyperphosphorylation
25%
Learning Disabilities
12%
Neurodegenerative Disorder
12%
Retrograde Nerve Fiber Transport
12%
Amyloid Precursor Protein
12%
Posttranslational Modification
12%
Axonal Degeneration
12%
Biochemistry, Genetics and Molecular Biology
Farnesyltransferase
100%
Nerve Fiber Degeneration
100%
Amyloid Protein
100%
Lysosome
16%
LAMP1
16%
Tau
16%
Hyperphosphorylation
16%
Mouse Model
8%
Posttranslational Modification
8%
Proteinopathy
8%
Enzyme
8%
Maturation
8%
Biogenesis
8%
Retrograde Nerve Fiber Transport
8%
Amyloid Precursor Protein
8%